assessed cartilage damage, MMP activity, and joint space
This is not an issue with an injection (since IM/IV bypasses the gut), but if a patient is also taking oral supplements, they should separate them from tetracycline dosing
Reported side effects are typically mild and transient: BPC-157: Nausea (rare), mild fatigue in the first week, minor injection site redness TB-500: Mild lethargy during the loading phase, transient head rush immediately after injection, injection site discomfort Combined stack: No documented synergistic toxicity in preclinical or clinical observational data The more significant risks relate to sourcing and administration rather than the peptides themselves
The challenge is that the enthusiasm for peptides has outpaced information and education
Semaglutide products, such as Wegovy, have been approved by the FDA for weight management in adults with obesity or certain related health risks